Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|15|9|857-871

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.9, 2015-05, pp. : 857-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3579-3594

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) against Oxidative Stress in Cardiovascular Related Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1465-1470

Bentham Science Publishers

Access to resources Recommend Favorite

The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 267-281

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases

By Parajuli Nirmal   Ramprasath Tharmarajan   Patel Vaibhav B.   Wang Wang   Putko Brendan   Mori Jun   Oudit Gavin Y.  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 558-565

NRC Research Press

Access to resources Recommend Favorite

Targeting the Nrf2 pathway against cardiovascular disease

By Li Jinqing   Ichikawa Tomonaga   Janicki Joseph S   Cui Taixing  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 785-794

Informa Healthcare

Access to resources Recommend Favorite